Date Time
Share
A leap forward in research on CAR T cell therapy – Cellular engineering makes it possible to target therapy also against solid
A study recently published in the journal Science looked into how CAR T immunotherapy could be used to treat solid tumours in addition to leukaemias. The programming of CAR T cells opens avenues for applying cell therapies to, for example, breast cancer or ovarian cancer in the future.
In cancer immunotherapy, cells in the patient’s own immune system are activated to attack cancer cells. CAR T cell therapy has been one of the most significant recent advances in immunotherapies targeted at cancer.
COVID vaccinations open up to all, people rush to book shots
LEAH WILLINGHAM, Associated Press/Report for America
March 16, 2021
FacebookTwitterEmail
JACKSON, Miss. (AP) Appointments to get the coronavirus vaccine in Mississippi opened up for everyone over the age of 16 on Tuesday, and thousands of residents rushed to book their shots.
Robin McCall made appointments for her 17-year-old twin daughters. She has a 15-year-old son who has been treated for leukemia.
“He has a compromised immune system so these vaccines for our family are very important for him,” said McCall, who got vaccinated weeks ago because she has a heart condition that made her eligible.
Triathlete s battle with cancer and his race to the finish line
and last updated 2021-03-15 07:30:58-04
LAFAYETTE â Over 700 contestants from around the country showed up to partake in the Zydeco Marathon on Sunday morning in Downtown Lafayette, but one contestant stood out among the rest for his inspirational story about his race to beat cancer.
Daniel Allemond is a long-time runner who s marathon days were cut short in September of 2015, when he was diagnosed with Leukemia. At one point I was paralyzed on the right side of my body, says Allemond. I had Encephalitis, which is swelling of the brain.
Cancer cells may dodge chemotherapy by going into active hibernation
Cancer cells can dodge chemotherapy by entering a state that bears similarity to certain kinds of senescence, a type of active hibernation that enables them to weather the stress induced by aggressive treatments aimed at destroying them, according to a new study by scientists at Weill Cornell Medicine. These findings have implications for developing new drug combinations that could block senescence and make chemotherapy more effective.
In a study published Jan. 26 in
Cancer Discovery, a journal of the American Association for Cancer Research, the investigators reported that this biologic process could help explain why cancers so often recur after treatment. The research was done in both organoids and mouse models made from patients samples of acute myeloid leukemia (AML) tumors. The findings were also verified by looking at samples from AML patients that were collected throughout the course of treatment and